FDA Posts Bisphosphonates Warning
Yesterday, the FDA formally informed healthcare professionals and patients of the possibility of severe and sometimes incapacitating bone, joint, and/or muscle (musculoskeletal) pain in patients taking bisphosphonates. This severe musculoskeletal pain discussed in this alert is in contrast to the acute phase response characterized by fever, chills, bone pain, myalgias, and arthralgias that sometimes accompanies [...]
